David J. Brooks
Orcid: 0000-0003-2602-2518Affiliations:
- Imperial College London, Centre for Neuroscience, Department of Medicine, London, UK
- Aarhus University, Institute of Clinical Medicine, Denmark
According to our database1,
David J. Brooks authored at least 25 papers
between 2002 and 2024.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on orcid.org
On csauthors.net:
Bibliography
2024
Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait.
NeuroImage, 2024
2016
Using [<sup>11</sup>C]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism.
NeuroImage, 2016
2014
Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [<sup>11</sup>C]MePPEP.
NeuroImage, 2014
2013
Binary classification of <sup>18</sup>F-flutemetamol PET using machine learning: Comparison with visual reads and structural MRI.
NeuroImage, 2013
Quantification of opioid receptor availability following spontaneous epileptic seizures: Correction of [<sup>11</sup>C]diprenorphine PET data for the partial-volume effect.
NeuroImage, 2013
Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
NeuroImage, 2013
2012
[<sup>18</sup>F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [<sup>18</sup>F]FDOPA and [<sup>11</sup>C]DASB PET study in Parkinson's disease.
NeuroImage, 2012
Can target-to-pons ratio be used as a reliable method for the analysis of [<sup>11</sup>C]PIB brain scans?
NeuroImage, 2012
2011
Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal <sup>18</sup>F-dopa PET study.
NeuroImage, 2011
Proceedings of the 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2011
2010
Subject classification from [18F]flutemetamol data into categories of raised or low levels of beta-amyloid: Concordance between quantitative and visual assessment.
NeuroImage, 2010
NeuroImage, 2010
Correction of [11C]diprenorphine PET data for the partial-volume effect: Quantification of opioid receptor binding following spontaneous epileptic seizures.
NeuroImage, 2010
Pons as an alternative reference region in [18F]flutemetamol quantification of amyloidosis.
NeuroImage, 2010
Kinetic modeling of the adenosine A2A subtype receptor radioligand [11C]SCH442416 in humans.
NeuroImage, 2010
Quantitation of adenosine A2A receptors availability in Parkinson's Disease patients with and without dyskinesias with [11C]SCH442416 PET using spectral analysis.
NeuroImage, 2010
Investigating the reproducibility of the novel Alpha-5 GABAA receptor PET ligand [11C]Ro15 4513.
NeuroImage, 2010
2009
Strategies for the generation of parametric images of [<sup>11</sup>C]PIB with plasma input functions considering discriminations and reproducibility.
NeuroImage, 2009
2008
Res. Comput. Sci., 2008
2007
Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [<sup>11</sup>C]diprenorphine test-retest data.
NeuroImage, 2007
A systematic comparison of kinetic modelling methods generating parametric maps for [<sup>11</sup>C]-(R)-PK11195.
NeuroImage, 2007
Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus.
NeuroImage, 2007
2006
Proceedings of the Tenth Conference on Computational Natural Language Learning, 2006
2002
A H<sub>2</sub><sup>15</sup>O Positron Emission Tomography Study on Mental Imagery of Movement Sequences - The Effect of Modulating Sequence Length and Direction.
NeuroImage, 2002